Key findings from the 2018 Western Australia Ecstasy and Related Drugs Reporting System
Jodie Grigg presented key findings from the 2018 Western Australia Ecstasy and Related Drugs Reporting System interviews as part of a National Drug Research Institute public seminar on Thursday, 28 February.
Key conclusions include:
The demographic characteristics of the sample are largely unchanged, although we observe fluctuations in the gender breakdown across years.
Following significant ecstasy shortages around 2011, the ecstasy market has gradually made a full resurgence and there are indications it’s stronger than ever. 2018 observed record highs in the popularity of the drug and perceptions of purity, coupled with record lows in price.
The market has also significantly diversified and now features a variety of different forms of ecstasy, all of which are perceived by most as easy to access, particularly pills and capsules.
Despite record low prices, current data do not show an increasing trend in frequency of use. Although, use of capsule forms may be increasing.
In contrast to national trends, reports of non-fatal stimulant overdoses in the Perth sample have been decreasing since about 2011.
Drugs which have been increasing over time include cocaine, benzodiazepines, ketamine and nitrous oxide (all drugs observed record highs in 2018).
The data suggest the darknet may now play a significant role in the supply of ecstasy and related drugs within WA.